Ziv, M. N., Patel, M. P., Minor, M., Johnson, M. O., Batich, K., Low, J., … Peters, K. B. (2024). INNV-37. REAL-WORLD OUTCOMES AMONG HIGH GRADE IDH1-MUTANT GLIOMA PATIENTS TREATED WITH AN IDH INHIBITOR. In Neuro-Oncology (Vol. 26, pp. viii176–viii177). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noae165.0698

Ziv, Michal Nisnboym, Mallika P. Patel, Maria Minor, Margaret O. Johnson, Kristen Batich, Justin Low, Madison L. Shoaf, et al. “INNV-37. REAL-WORLD OUTCOMES AMONG HIGH GRADE IDH1-MUTANT GLIOMA PATIENTS TREATED WITH AN IDH INHIBITOR.” In Neuro-Oncology, 26:viii176–77. Oxford University Press (OUP), 2024. https://doi.org/10.1093/neuonc/noae165.0698.

Ziv MN, Patel MP, Minor M, Johnson MO, Batich K, Low J, et al. INNV-37. REAL-WORLD OUTCOMES AMONG HIGH GRADE IDH1-MUTANT GLIOMA PATIENTS TREATED WITH AN IDH INHIBITOR. In: Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii176–7.

Ziv, Michal Nisnboym, et al. “INNV-37. REAL-WORLD OUTCOMES AMONG HIGH GRADE IDH1-MUTANT GLIOMA PATIENTS TREATED WITH AN IDH INHIBITOR.” Neuro-Oncology, vol. 26, no. Supplement_8, Oxford University Press (OUP), 2024, pp. viii176–77. Crossref, doi:10.1093/neuonc/noae165.0698.

Ziv MN, Patel MP, Minor M, Johnson MO, Batich K, Low J, Shoaf ML, Khasraw M, Desjardins A, Friedman HS, Ashley DM, Peters KB. INNV-37. REAL-WORLD OUTCOMES AMONG HIGH GRADE IDH1-MUTANT GLIOMA PATIENTS TREATED WITH AN IDH INHIBITOR. Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii176–viii177.